ask="7.45"
ask_size="400"
average_daily_volume="331798"
bid="3.00"
bid_size="200"
book_value="3.69"
change="-0.10"
change_from_200_day_moving_average="-3.63"
change_from_50_day_moving_average="-3.53"
change_from_52_week_high="-7.75"
change_From_52_week_low="2.97"
change_in_percent="-1.44%"
close="6.85"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.17"
ebitda="-38.95M"
eps_estimate_current_year="-2.14"
eps_estimate_next_quarter="-0.52"
eps_estimate_next_year="-2.05"
ex_dividend_date="N/A"
float_shares="16060000"
high="7.15"
high_52_weeks="14.60"
last_trade_date="2/10/2017"
last_trade_price="6.85"
last_trade_size="16344"
last_trade_time="4:00pm"
low="6.75"
low_52_weeks="3.88"
market_capitalization="122.25M"
moving_average_200_day="10.48"
moving_average_50_day="10.38"
name="Stemline Therapeutics
Inc."
notes="N/A"
one_year_target_price="25.50"
open="6.95"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-34.61%"
percent_change_from_50_day_moving_average="-34.00%"
percent_change_from_52_week_high="-53.08%"
percent_change_from_52_week_low="+76.55%"
previous_close="6.95"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.89"
price_per_sales="130.89"
revenue="947604.00"
shares_outstanding="17846000"
short_ratio="7.27"
stock_exchange="NCM"
symbol="STML"
volume="395024"
weeks_range_52="3.88 - 14.60"
